Skip to main content
HARVARD BIOSCIENCE INC logo

HARVARD BIOSCIENCE INC — Investor Relations & Filings

Ticker · HBIO ISIN · US4169061052 LEI · 549300VLGB1D47GGC642 US Manufacturing
Filings indexed 1,020 across all filing types
Latest filing 2022-07-12 Director's Dealing
Country US United States of America
Listing US HBIO

About HARVARD BIOSCIENCE INC

https://www.harvardbioscience.com/

Harvard Bioscience is a global developer, manufacturer, and marketer of technologies, products, and services for the life science research and drug discovery markets. The company provides a broad range of specialized scientific instruments, systems, software, and consumables that support fundamental research, preclinical studies, production, and safety compliance. Key product areas include instrumentation for electrophysiology, such as patch clamp amplifiers and multi-electrode array (MEA) systems; preclinical monitoring systems for physiological data like glucose levels, temperature, and activity in animal models; and spectrophotometry instruments for quality control applications. The company also offers specialized software, including the Ponemah® platform, for data acquisition and analysis, with capabilities for GLP and 21 CFR part 11 compliance. Its solutions are designed to enable the discovery, safety, and production of new therapeutics.

Recent filings

Filing Released Lang Actions
OWNERSHIP DOCUMENT
Director's Dealing
2022-07-12 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-07-08 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-06-21 English
OWNERSHIP DOCUMENT
Director's Dealing
2022-06-17 English
OWNERSHIP DOCUMENT
Director's Dealing
2022-06-14 English
OWNERSHIP DOCUMENT
Director's Dealing
2022-06-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.